Reversible left ventricular hypertrophy after tako-tsubo-like cardiomyopathy.
Tako-tsubo-like cardiomyopathy is a newly-recognized enigmatic disease characterized by transient left ventricular dysfunction of a broad area of the apex with a hyperkinetic area around the cardiac base. There is ST-segment elevation with no coronary stenosis. The exact mechanism for this entity remains unknown. Here, we report a case of tako-tsubo-like cardiomyopathy that showed a marked left ventricular hypertrophy (LVH) when the wall motion returned to normal. LVH was normalized at 10 months. The cause of LVH remains unknown.
Higashikuni
Yasutomi
Y
Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Sata
Masataka
M
Nagai
Ryozo
R
D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000175:diagnosis*; D002637:Chest Pain / Q000175:diagnosis / Q000209:etiology; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D009543:Nifedipine / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D013777:Tetrazoles / Q000627:therapeutic use; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy
D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D009543:Nifedipine; D001241:Aspirin; C081643:candesartan